SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-136435
Filing Date
2022-05-02
Accepted
2022-05-02 14:24:09
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d212187d10ka.htm   iXBRL 10-K/A 424161
2 EX-31.03 d212187dex3103.htm EX-31.03 3230
3 EX-31.04 d212187dex3104.htm EX-31.04 3242
  Complete submission text file 0001193125-22-136435.txt   660710

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cbio-20211231.xsd EX-101.SCH 4769
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20211231_cal.xml EX-101.CAL 750
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20211231_def.xml EX-101.DEF 1755
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20211231_lab.xml EX-101.LAB 21578
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20211231_pre.xml EX-101.PRE 17542
10 EXTRACTED XBRL INSTANCE DOCUMENT d212187d10ka_htm.xml XML 6598
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51173 | Film No.: 22881197
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences